Most Clicked StoriesMore >


List of medical events for pharmacovigilance issued by EMA

DIA Global SmartBrief | Aug 23, 2016

A list of 62 standardized terms describing medical events that could occur after using health care products has been released by the European Medicines Agency to aid in the agency's pharmacovigilance activities and prioritize the review of suspected adverse events that require additional attention. The list of criteria was created by the EudraVigilance Expert Working Group from definitions for serious medical events adopted by the International Conference on Harmonization. Regulatory Focus (08/19)


Pfizer's products from India plant banned in EU due to GMP deficiencies

DIA Global SmartBrief | Aug 23, 2016

Swiss researchers develop cost-cutting method for API production

DIA Global SmartBrief | Aug 25, 2016

Final guidances related to benefit-risk determinations released by FDA

DIA Global SmartBrief | Aug 25, 2016

Enbrel biosimilar Brenzys backed by Australian advisory body

DIA Global SmartBrief | Aug 25, 2016

Summer is almost over -- have you scheduled your team's 2016 professional development training with DIA?

DIA Global SmartBrief | Aug 25, 2016

Next-gen blood glucose-monitoring system debuted by Roche unit

DIA Global SmartBrief | Aug 25, 2016

Explore the new August Global Forum

DIA Global SmartBrief | Aug 23, 2016

Pfizer's abuse-deterrent opioid painkiller wins FDA nod

DIA Global SmartBrief | Aug 23, 2016

Drugmakers seek additional guidance on chewables

DIA Global SmartBrief | Aug 23, 2016


Find DIA Global SmartBrief Issues by Date:



DIA News More >


Customized Onsite Training

DIA Global SmartBrief | Aug 30, 2016

Summer is almost over -- have you scheduled your team's 2016 professional development training with DIA?

DIA Global SmartBrief | Aug 25, 2016

Explore the new August Global Forum

DIA Global SmartBrief | Aug 23, 2016

Advance thought leadership in the July Journal

DIA Global SmartBrief | Aug 11, 2016




Sign up for DIA Global SmartBrief



Designed specifically for the global drug development professional, the DIA Global SmartBrief is a FREE, twice weekly e-mail newsletter. By providing the latest need-to-know industry news and information, the DIA Global SmartBrief saves you time and keeps you smart. Learn more